Association between levels of serum perfluorooctane sulfate and carotid artery intima-media thickness in adolescents and young adults

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3309-3316

  Lin, Chien Yu ^a,b   Lin, Lian Yu ^c   Wen, Ting Wen ^d   Lien, Guang Wen ^d   Chien, Kuo Liong ^d   Hsu, Sandy H J ^c   Liao, Chien Chang ^e   Sung, Fung Chang ^f   Chen, Pau Chung ^d   Su, Ta Chen ^c  

^a EN CHU KONG HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Carotid intima media thickness; Perfluorinated chemicals; Perfluorononanoic acid; Perfluorooctane sulfate

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; C REACTIVE PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PERFLUORO COMPOUND; PERFLUORODECANOIC ACID; PERFLUORONONANOIC ACID; PERFLUOROOCTANE SULFATE; PERFLUOROOCTANOIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

CAROTID INTIMA-MEDIA THICKNESS; PERFLUORINATED CHEMICALS; PERFLUORONONANOIC ACID; PERFLUOROOCTANE SULFATE;

ADOLESCENT; ADULT; ALKANESULFONIC ACIDS; BIOLOGICAL MARKERS; CAROTID INTIMA-MEDIA THICKNESS; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FLUOROCARBONS; FOLLOW-UP STUDIES; HUMANS; MALE; YOUNG ADULT;

EID: 84886249620     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.04.042     Document Type: Article

References (69)

1. M. Houde, J.W. Martin, R.J. Letcher, K.R. Solomon, and D.C. Muir Biological monitoring of polyfluoroalkyl substances: a review Environ Sci Technol 40 2006 3463 3473
2. Amending Regulation (EC) No 850/2004 of the European Parliament and of the Council on persistent organic pollutants as regards Annexes I and III Off J Eur Union 223 2010 29 36
3. C. Lau, K. Anitole, C. Hodes, D. Lai, A. Pfahles-Hutchens, and J. Seed Perfluoroalkyl acids: a review of monitoring and toxicological findings Toxicol Sci 99 2007 366 394
4. L.S. Haug, C. Thomsen, and A.L. Brantsaeter Diet and particularly seafood are major sources of perfluorinated compounds in humans Environ Int 36 2010 772 778
5. L.B. Biegel, M.E. Hurtt, S.R. Frame, J.C. O'Connor, and J.C. Cook Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats Toxicol Sci 60 2001 44 55
6. A.M. Seacat, P.J. Thomford, and K.J. Hansen Sub-chronic dietary toxicity of potassium perfluorooctane sulfonate in rats Toxicology 183 2003 117 131
7. J. Butenhoff, G. Costa, and C. Elcombe Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months Toxicol Sci 69 2002 244 257
8. Q. Yang, Y. Xie, S.E. Alexson, B.D. Nelson, and J.W. DePierre Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice Biochem Pharmacol 63 2002 1893 1900
9. C. Lau, J.R. Thibodeaux, and R.G. Hanson Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation Toxicol Sci 74 2003 382 392
10. M.E. Andersen, J.L. Butenhoff, and S.C. Chang Perfluoroalkyl acids and related chemistries - toxicokinetics and modes of action Toxicol Sci 102 2008 3 14
11. T. Chen, L. Zhang, and J.Q. Yue Prenatal PFOS exposure induces oxidative stress and apoptosis in the lung of rat offspring Reprod Toxicol 33 4 2012 538 545
12. X. Shi, and B. Zhou The role of Nrf2 and MAPK pathways in PFOS-induced oxidative stress in zebrafish embryos Toxicol Sci 115 2010 391 400
13. S.E. Loveless, C. Finlay, and N.E. Everds Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO) Toxicology 220 2006 203 217
14. A.M. Seacat, P.J. Thomford, K.J. Hansen, G.W. Olsen, M.T. Case, and J.L. Butenhoff Subchronic toxicity studies on perfluorooctane sulfonate potassium salt in cynomolgus monkeys Toxicol Sci 68 2002 249 264
15. X.Z. Hu, and D.C. Hu Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells Arch Toxicol 83 2009 851 861
16. K.T. Eriksen, O. Raaschou-Nielsen, M. Sorensen, M. Roursgaard, S. Loft, and P. Moller Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, PFNA and PFHxA in human HepG2 cells Mutat Res 700 2010 39 43
17. Y. Qian, A. Ducatman, and R. Ward Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability J Toxicol Environ Health A 73 2010 819 836
18. D.M. Thorsten Stahl, and Hubertus Brunn Toxicology of perfluorinated compounds Environ Sci Eur 23 2011 38
19. F.D. Gilliland, and J.S. Mandel Mortality among employees of a perfluorooctanoic acid production plant J Occup Med 35 1993 950 954
20. B.H. Alexander, G.W. Olsen, J.M. Burris, J.H. Mandel, and J.S. Mandel Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility Occup Environ Med 60 2003 722 729
21. C.J. Sakr, K.H. Kreckmann, J.W. Green, P.J. Gillies, J.L. Reynolds, and R.C. Leonard Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers J Occup Environ Med 49 2007 1086 1096
22. C.J. Sakr, R.C. Leonard, K.H. Kreckmann, M.D. Slade, and M.R. Cullen Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate J Occup Environ Med 49 2007 872 879
23. S.J. Frisbee, A. Shankar, and S.S. Knox Perfluorooctanoic acid, perfluorooctane sulfonate, and serum lipids in children and adolescents: results from the C8 Health Project Arch Pediatr Adolesc Med 164 2010 860 869
24. K. Steenland, S. Tinker, S. Frisbee, A. Ducatman, and V. Vaccarino Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant Am J Epidemiol 170 2009 1268 1278
25. K. Steenland, S. Tinker, A. Shankar, and A. Ducatman Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA Environ Health Perspect 118 2010 229 233
26. J.W. Nelson, E.E. Hatch, and T.F. Webster Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population Environ Health Perspect 118 2010 197 202
27. D. Melzer, N. Rice, M.H. Depledge, W.E. Henley, and T.S. Galloway Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey Environ Health Perspect 118 2010 686 692
28. C.Y. Lin, L.L. Wen, and L.Y. Lin The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults J Hazard Mater 244-245 2013 637 644
29. C.Y. Lin, L.Y. Lin, and C.K. Chiang Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults Am J Gastroenterol 105 2010 1354 1363
30. C.Y. Lin, P.C. Chen, Y.C. Lin, and L.Y. Lin Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults Diabetes Care 32 2009 702 707
31. J.I. Lundin, B.H. Alexander, G.W. Olsen, and T.R. Church Ammonium perfluorooctanoate production and occupational mortality Epidemiology 20 2009 921 928
32. C.J. Sakr, J.M. Symons, K.H. Kreckmann, and R.C. Leonard Ischaemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate Occup Environ Med 66 2009 699 703
33. M. Zureik, P. Ducimetiere, and P.J. Touboul Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study Arterioscler Thromb Vasc Biol 20 2000 1622 1629
34. A. Simon, J. Gariepy, G. Chironi, J.L. Megnien, and J. Levenson Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk J Hypertens 20 2002 159 169
35. M.L. Bots, A.W. Hoes, P.J. Koudstaal, A. Hofman, and D.E. Grobbee Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study Circulation 96 1997 1432 1437
36. H.N. Hodis, W.J. Mack, and L. LaBree The role of carotid arterial intima-media thickness in predicting clinical coronary events Ann Intern Med 128 1998 262 269
37. K.L. Chien, T.C. Su, and J.S. Jeng Carotid artery intima-media thickness, carotid plaque and coronary heart disease and stroke in Chinese PLoS One 3 2008 e3435
38. D.H. Lee, I.K. Lee, and K. Song A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002 Diabetes Care 29 2006 1638 1644
39. D. Li, Z. Zhou, and D. Qing Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction Hum Reprod 25 2010 519 527
40. S.M. Engel, A. Miodovnik, and R.L. Canfield Prenatal phthalate exposure is associated with childhood behavior and executive functioning Environ Health Perspect 118 2010 565 571
41. P.M. Lind, and L. Lind Circulating levels of bisphenol A and phthalates are related to carotid atherosclerosis in the elderly Atherosclerosis 218 2011 207 213
42. P.M. Lind, B. van Bavel, S. Salihovic, and L. Lind Circulating levels of persistent organic pollutants (POPs) and carotid atherosclerosis in the elderly Environ Health Perspect 120 2011 38 43
43. J.N. Wei, F.C. Sung, C.C. Lin, R.S. Lin, C.C. Chiang, and L.M. Chuang National surveillance for type 2 diabetes mellitus in Taiwanese children JAMA 290 2003 1345 1350
44. C.Y. Lin, L.L. Wen, and L.Y. Lin Associations between levels of serum perfluorinated chemicals and adiponectin in a young hypertension cohort in Taiwan Environ Sci Technol 45 2011 10691 10698
45. C.W. Tsai, C.C. Kuo, and C.F. Wu Associations of renal vascular resistance with albuminuria in adolescents and young adults Nephrol Dial Transplant 26 2011 3943 3949
46. T.M. Wallace, J.C. Levy, and D.R. Matthews Use and abuse of HOMA modelling Diabetes Care 27 2004 1487 1495
47. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents Pediatrics 114 2004 555 576
48. T.C. Su, Y.T. Lee, S. Chou, W.T. Hwang, C.F. Chen, and J.D. Wang Twenty-four-hour ambulatory blood pressure and duration of hypertension as major determinants for intima-media thickness and atherosclerosis of carotid arteries Atherosclerosis 184 2006 151 156
49. T.C. Su, K.L. Chien, and J.S. Jeng Age- and gender-associated determinants of carotid intima-media thickness: a community-based study J Atheroscler Thromb 19 2012 872 880
50. J.F. Polak, S.D. Person, and G.S. Wei Segment-specific associations of carotid intima-media thickness with cardiovascular risk factors. The Coronary Artery Risk Development in Young Adults (CARDIA) Study Stroke 41 2010 9 15
51. G.W. Lien, T.W. Wen, W.S. Hsieh, K.Y. Wu, C.Y. Chen, and P.C. Chen Analysis of perfluorinated chemicals in umbilical cord blood by ultra-high performance liquid chromatography/tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 879 2011 641 646
52. P.W. Wilson, R.H. Myers, M.G. Larson, J.M. Ordovas, P.A. Wolf, and E.J. Schaefer Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study JAMA 272 1994 1666 1671
53. M.O. McCarron, D. Delong, and M.J. Alberts APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis Neurology 53 1999 1308 1311
54. R. Elosua, J.M. Ordovas, and L.A. Cupples Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study J Lipid Res 45 2004 1868 1875
55. L. Paternoster, N.A. Martinez Gonzalez, S. Lewis, and C. Sudlow Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke Stroke 39 2008 48 54
56. P. Pantelidis, M. Lambert-Hammill, and A.S. Wierzbicki Simple sequence-specific-primer-PCR method to identify the three main apolipoprotein E haplotypes Clin Chem 49 2003 1945 1948
57. A.M. Calafat, L.Y. Wong, Z. Kuklenyik, J.A. Reidy, and L.L. Needham Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000 Environ Health Perspect 115 2007 1596 1602
58. A.Y. Lin, S.C. Panchangam, and C.C. Lo The impact of semiconductor, electronics and optoelectronic industries on downstream perfluorinated chemical contamination in Taiwanese rivers Environ Pollut 157 2009 1365 1372
59. W. Hu, P.D. Jones, and W. DeCoen Alterations in cell membrane properties caused by perfluorinated compounds Comp Biochem Physiol C Toxicol Pharmacol 135 2003 77 88
60. F.S. vom Saal, and J.P. Myers Bisphenol A and risk of metabolic disorders JAMA 300 2008 1353 1355
61. W.V. Welshons, S.C. Nagel, and F.S. vom Saal Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure Endocrinology 147 2006 S56 S69
62. J. Davignon, J.S. Cohn, L. Mabile, and L. Bernier Apolipoprotein E and atherosclerosis: insight from animal and human studies Clin Chim Acta 286 1999 115 143
63. J.L. Butenhoff, E. Pieterman, and D.J. Ehresman Distribution of perfluorooctanesulfonate and perfluorooctanoate into human plasma lipoprotein fractions Toxicol Lett 210 2012 360 365
64. G.W. Olsen, D.J. Ehresman, B.D. Buehrer, B.A. Gibson, J.L. Butenhoff, and L.R. Zobel Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of perfluoroalkyl manufacturing facilities J Occup Environ Med 54 2012 974 983
65. I.R. MacPherson, D. Bissett, and R.D. Petty A first-in-human phase I clinical trial of CXR1002 in patients with advanced cancer J Clin Oncol 29 2011 3063 [Suppl.; abstr]
66. M.L. Takacs, and B.D. Abbott Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate Toxicol Sci 95 2007 108 117
67. X. Fang, L. Zhang, Y. Feng, Y. Zhao, and J. Dai Immunotoxic effects of perfluorononanoic acid on BALB/c mice Toxicol Sci 105 2008 312 321
68. C.V. Breton, X. Wang, and W.J. Mack Childhood air pollutant exposure and carotid artery intima-media thickness in young adults Circulation 126 2012 1614 1620
69. M. Bauer, S. Moebus, and S. Mohlenkamp Urban particulate matter air pollution is associated with subclinical atherosclerosis: results from the HNR (Heinz Nixdorf Recall) study J Am Coll Cardiol 56 2010 1803 1808